The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Bone Marrow Origin of Myofibroblasts in Irradiation Pulmonary Fibrosis
Abstract
There is a rapid onset of organizing alveolitis/fibrosis at 120-140 d after whole lung irradiation of C57BL/6J mice. To test the hypothesis that circulating cells of bone marrow origin contribute to irradiation fibrosis, irradiated chimeric green fluorescent protein (GFP)+ C57BL/6J mice were followed for GFP+ cells in areas of lung fibrosis. In a second experimental model, C57BL/6J female mice received 20 Gy total lung irradiation, and after 60 or 80 d were intravenously injected with cells from a clonal GFP+ male bone marrow stromal cell line or male GFP+ whole bone marrow, respectively. The mice were then followed for the development of pulmonary fibrosis, and the contribution of Y-probe-positive, GFP+ cells to fibrotic areas was quantitated. Bromodeoxyuridine labeling of developing fibrotic areas showed that the cell division occurred predominantly in GFP+, Y-probe-positive, and vimentin-positive cells. Immunohistochemistry demonstrated that these cells were macrophages and fibroblasts, not endothelial cells. Mice that received manganese superoxide dismutase-plasmid/liposome intratracheal injection 24 h before total lung irradiation demonstrated a decrease in GFP+ fibroblastic cells in the lung. Thus, pulmonary irradiation fibrosis contains proliferating cells of bone marrow origin, and gene therapy prevention of this condition acts in part by decreasing the migration and proliferation of marrow origin cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S., & Sharkis, S. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00328-2 · Cited by 2,667
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Pereira, R. F., Halford, K. W., O'Hara, M. D., Leeper, D. B., Sokolov, B. P., Pollard, M. D., Bagasra, O., & Prockop, D. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4857 · Cited by 924
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
Martin, M., Lefaix, J.-L., & Delanian, S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00435-1 · Cited by 657
Bone marrow-derived cells as progenitors of lung alveolar epithelium
Kotton, D. N., Ma, B. Y., Cardoso, W. V., Sanderson, E. A., Summer, R. S., Williams, M. C., & Fine, A. (2001) · Development · doi:10.1242/dev.128.24.5181 · Cited by 559
Grimm, P. C., Nickerson, P., Jeffery, J., Savani, R. C., Gough, J., McKenna, R. M., Stern, E., & Rush, D. N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450203 · Cited by 269
Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Hocher, B., Schwarz, A., Fagan, K. A., Thöne-Reineke, C., El-Hag, K., Kusserow, H., Elitok, S., Bauer, C., Neumayer, H.-H., Rodman, D. M., et al. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.4030 · Cited by 219
Physical and biological predictors of changes in whole-lung function following thoracic irradiation
Marks, L. B., Munley, M. T., Bentel, G. C., Zhou, S.-M., Hollis, D., Scarfone, C., Sibley, G. S., Kong, F.-M., Jirtle, R., Jaszczak, R., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00343-x · Cited by 219
Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy
Epperly, M., Bray, J., Kraeger, S., Zwacka, R., Engelhardt, J., Travis, E., & Greenberger, J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300580 · Cited by 183
Self-citationEpperly, M. W., Bray, J. A., Krager, S., Berry, L. M., Gooding, W. E., Engelhardt, J. F., Zwacka, R. M., Travis, E. L., & Greenberger, J. S. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00355-1 · Cited by 158
Self-citation
Cited by
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Bone Marrow–Derived Mesenchymal Stem Cells in Repair of the Injured Lung
Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J., & Brigham, K. L. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0330oc · Cited by 848
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Cryptogenic organising pneumonia
Cordier, J.-F. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00013505 · Cited by 519
Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503
Epithelial Origin of Myofibroblasts during Fibrosis in the Lung
Willis, B. C., duBois, R. M., & Borok, Z. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-004tk · Cited by 500
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair
Gnecchi, M., Danieli, P., Malpasso, G., & Ciuffreda, M. C. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3584-0_7 · Cited by 449
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Animal Models of Fibrotic Lung Disease
B. Moore, B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 412
Therapeutic potential of mesenchymal stem cell-derived microvesicles
Biancone, L., Bruno, S., Deregibus, M. C., Tetta, C., & Camussi, G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs168 · Cited by 393
Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44
Li, Y., Jiang, D., Liang, J., Meltzer, E. B., Gray, A., Miura, R., Wogensen, L., Yamaguchi, Y., & Noble, P. W. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102510 · Cited by 382
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Andersson-Sjöland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramírez, R., Pardo, A., Westergren-Thorsson, G., & Selman, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.012 · Cited by 360
The reactive stroma microenvironment and prostate cancer progression
Barron, D. A., & Rowley, D. R. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0085 · Cited by 329
Lama, V. N., Smith, L., Badri, L., Flint, A., Andrei, A.-C., Murray, S., Wang, Z., Liao, H., Toews, G. B., Krebsbach, P. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29713 · Cited by 318
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
New Mechanisms of Pulmonary Fibrosis
Strieter, R. M., & Mehrad, B. (2009) · Chest · doi:10.1378/chest.09-0510 · Cited by 284
Circulating mesenchymal stem cells
Roufosse, C. A., Direkze, N. C., Otto, W. R., & Wright, N. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.007 · Cited by 282
The role of CXC chemokines in pulmonary fibrosis
Strieter, R. M., Gomperts, B. N., & Keane, M. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30562 · Cited by 273
Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
Shao, D. D., Suresh, R., Vakil, V., Gomer, R. H., & Pilling, D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107782 · Cited by 272
Pulmonary hypertension in interstitial lung disease: Fig. 1—
Behr, J., & Ryu, J. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00171307 · Cited by 263
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230
The Development of Serum Amyloid P as a Possible Therapeutic
Pilling, D., & Gomer, R. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02328 · Cited by 92
Conese, M., Piro, D., Carbone, A., Castellani, S., & Di Gioia, S. (2014) · The Scientific World Journal · doi:10.1155/2014/859817 · Cited by 28
“Increasing evidence obtained, particularly in mouse models, suggests that circulating fibrocytes can contribute to the pathophysiology of fibrotic lung diseases [68–74], pulmonary hypertension [74, 75], and severe asthma [74– 76], and thus may be a potential therapeutic target.”
Background
Metadata
- Authors
- Epperly, M. W., Guo, H., Gretton, J. E., & Greenberger, J. S.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08
- Volume
- 29
- Issue
- 2
- Pages
- 213-224
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W1981654793
- Cited by
- 265
- References
- 22
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.